Bausch Health Companies (BHC) Short-term Investments (2009 - 2026)

Bausch Health Companies has reported Short-term Investments for 16 years, with the latest figure at $13.0 million in Q2 2026.

• Quarterly Short-term Investments fell 18.75% year-over-year to $13.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $13.0 million (down 18.75% YoY) and the FY2025 annual result came in at $16.0 million, down 20.0% from the prior year.
• Short-term Investments was little changed at $13.0 million in Q2 2026 per BHC's latest filing, from $13.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $1.2 billion in Q2 2022 and troughed at $9.0 million in Q2 2023.
• A 5-year average of $152.2 million and a median of $20.0 million in 2023 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2023 and 2024: Short-term Investments plunged 99.26% in 2023, then surged 211.11% in 2024.
• Over 5 years, Short-term Investments stood at $27.0 million in 2022, then sank by 44.44% to $15.0 million in 2023, then jumped by 33.33% to $20.0 million in 2024, then slipped by 20.0% to $16.0 million in 2025, then fell by 18.75% to $13.0 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $13.0 million, $13.0 million, and $16.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.